Mutual and CCNC: What s the Difference?

Similar documents
How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD

Medicaid Transformation

In accordance with Act 124 of 2018 (H.914)

Opportunities on the Horizon. CCWJC/CCPN Provider Meeting Update November 2 nd, 2017

Support and pass provider status legislation in the House and Senate (H.R. 592/S. 109).

North Carolina Medical Society 2015 Medicaid Reform Analysis Updated 07/15/15

Health Care Compliance Association: Medicare Part D Compliance Conference

Adopting Multi-Payer and All- Payer Payment Models in States OCTOBER 25, 2016 WASHINGTON MARRIOTT WARDMAN PARK HOTEL WASHINGTON, DC

Centers for Medicare & Medicaid Services: Innovation Center New Direction Request For Information: Medicare Advantage (MA) Innovation Models

Advancing Risk Capability in 2015: Medicare Shared Savings Program and ACO Investment Model. March 23, 2015 // 12:00 P.M. 1:00 P.M.

A Practical Discussion of Value and Quality Based Payments What Do I Do Now?

North Carolina Medicaid Reform Status Briefing

MassHealth Section 1115 Waiver Summary. Key provisions:

Value Based Contracting

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

2017 EMPLOYER SERIES. 6 Things Employers Need to Know About Rising Health Care Costs. Cost Management Key Findings

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA

Network Adequacy Standards Constance L. Akridge July 21, 2016

Challenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare

NUTS AND BOLTS TRAINING FOR LEGISLATORS:

Trekking Towards Value Based Payments

THIRD-PARTY PHARMACY RECONCILIATION

Developing a Sustainable

August 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C.

Establish fair elmbursements

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Medicare Advantage Value-Based Insurance Design: Considerations and implications

Investor Presentation. August 2007

Vermont Medicaid Next Generation Pilot Program 2017 Performance

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

April 8, Dear Mr. Levinson,

OHSU Center for Evidence-based Policy Rhonda Anderson, RPh Director of Pharmacy National Conference of State Legislators San Diego, CA December 10,

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Clinically Integrated Networks and Population Health The next chapter in healthcare

CMS 1701 P UnityPoint Health. October 16, 2018

AFFORDABILITY REVIEW. Mysteries of the Medical Loss Ratio

HPM Institute Live National Podcast: "How Brokers Can Use Technology to Help Clients Achieve Lower Health Costs and Better Health Outcomes"

Standing strong for payers and patients

October 6, Re: Notice of Benefit and Payment Parameters for 2018; CMS-9934-P. Submitted electronically via

NCPA Summary of CMS Medicaid Covered Outpatient Drugs AMP Final Rule Prepared January NCPA Advocacy at Work

Aetna Group Medicare Advantage Frequently Asked Questions

Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations Proposed Rule

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT

Iowa Medicaid Synopsis of Managed Medicaid Request for Proposal

Payer Channel Forecasting and Analysis. Patrick J. Park, PharmD, MBA Director, Business Decision Support Daiichi Sankyo, Inc.

Date: February 21, 2018 TO: Interested Parties. RE: Continuity of Care through transition to new managed care arrangements

Unique PBM Capabilities

Subpart D MCO, PIHP and PAHP Standards Availability of services.

JOINT TASK FORCE ON HEALTH CARE COST REVIEW (Senate Bill 419)

HealthChoice Illinois

Approved Models to Align Incentives between Hospitals and their Physicians

Improving health care affordability Helping health plans bend the cost curve

The Emergence of Value-Based Care: Present and Future Tense

Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion

HIV Contracting for Public Health Departments

House Health Committee June 1, Department of Health and Human Services Medicaid Reform 1115 Waiver Submission

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

GMCB Update Health Reform Oversight Committee. Chair Kevin Mullin and Michael Barber October 25, 2018

Risk Adjusted Episodes as Benchmarks for ACOs: A Society of Actuaries Sponsored Study

THE NEW YORK STATE DSRIP PLAN: SUMMARY OF KEY ELEMENTS

Modernizing Louisiana s Medicaid

Public Notice for Iowa Wellness Plan 1115 Waiver and Marketplace Choice Plan 1115 Waiver

PRACTICE TRANSFORMATION. Moving Towards A Future of Team Based Care. Michael A. Kolber, PhD, MD

The Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017

Session 115IF, Provider Risk-Sharing Arrangements in Medicaid. Presenters: Puneet Budhiraja, ASA, MAAA Michael Minor Sudha Shenoy, FSA, MAAA, CERA

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

Better Medicare Alliance Webinar: Medicare Advantage and Part D 2019 Advance Notice and Draft Call Letter. February 8, 2018

Presentation to the IOM Committee on Core Metrics Tom Williams, Dr PH, President & CEO, IHA January 7, 2014, Irvine, California

MEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT

PERFORMANCE AND TRAJECTORY

Configuration of Network and Financial Management Systems to Support Multiple Value Based Reimbursement Models

CMS s 2018 Proposed Medicaid Managed Care Rule: A Summary of Major Provisions

OHSU Center for Evidence-based Policy Rhonda Anderson, RPh Director of Pharmacy EMPAA 2017 October 30, 2017

TECHNOLOGY-ENABLED CARE COORDINATION AGREEMENT

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements

Providers Contracting Directly With Employers

Compensation and Reimbursement

Medicaid in a Time of Historic Change: Prescription Drugs and Costs A Medicaid Perspective

10/17/2014 Risk-Based Payment Methodologies A National Perspective Art Jones, MD. AccountableCareInstitute.com

Data Submission Guide (DSG) Training Webinar The Arkansas Healthcare Transparency Initiative and the Arkansas All-Payer Claims Database (APCD)

2018 Medicare Advantage and Part D Rate Announcement and Call Letter, and Request

FRH18EOC88V1. Evidence of Coverage. Freedom Platinum Plan Rx (HMO) H5427_2018_AEOC_088_Aug2017_CMS Accepted

Medicaid and CHIP Managed Care Final Rule (CMS-2390-F) Overview of the Final Rule. Center for Medicaid and CHIP Services

Health care affordability VBC transformation

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark

Overview of 1115 Waivers

DIR fees are knocking down pharmacy profits

Before prescribing ZYTIGA (abiraterone acetate), please see accompanying full Prescribing Information. Help simplify starting and staying on ZYTIGA

The ACO Effort: A Status Report

The Management of Specialty Drugs: Opportunities and Challenges

TECHNOLOGY-ENABLED CARE COORDINATION AGREEMENT

Health Plan Design Options August 23, 2012

Medicare Comprehensive ESRD Care (CEC) Initiative

Evidence of Coverage:

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

Healthcare Reform. North Carolina Dietetic Association September 12, Duke Medicine

Karen McLeod, MSW President/CEO

Medicaid MCO Network Adequacy Overview June 2016 JAMIE DUDENSING, CEO Texas Association of Health Plans

No change from proposed rule. healthcare providers and suppliers of services (e.g.,

Transcription:

Mutual and CCNC: What s the Difference?

Objectives Review the history and current status of the CMMI grant Discuss the transition from CCNC to CPESN and how Mutual fits in Discuss how local networks (Mutual CPESN) engage with national efforts (CPESN USA) Review current opportunities for participating pharmacies Review mechanics of CPESN USA and Mutual CPESN Participation

CMMI Year 4 Update September 1, 2017 to August 31, 2018 (but funds for payments to pharmacies may run out sooner) 232 pharmacies in year 4 Focus on sustainability mode Pharmacist ecare Plan instead of PHARMACeHOME Alternative payment model that accounts for both risk level of the patient and pharmacy performance

CCNC Practice Relationships Pre & Post Medicaid Reform CCNC CCNC CA-II Primary Care Practices (CCNC- Enrolled) CPESN Pharmacies Community Care Physicians Network (CCPN) Mutual CPESN (1 of 37+ CPESN networks nationally) Clinically Integrated Networks of Providers

NC Medicaid Reform References to CPESN Networks MARCH 2016 NC DHHS INITIAL WAIVER DRAFT North Carolina has launched several initiatives funded by CMS that focus on improving specialty care and integration. DHHS views this Demonstration as a clear opportunity to continue promoting CMS priorities while enhancing the medical home delivery model. These grants include: Community Pharmacy Enhanced Services Network. A CMMI grant to CCNC to develop a network of pharmacies that provide enhanced services, such as synchronization of a patient s chronic medication fill dates, adherence monitoring and coaching, compliance packaging, and home delivery. AUGUST 2017 NC DHHS WHITE PAPER ON REFORM EFFORTS Community Pharmacy Programs. DHHS is exploring opportunities to leverage pharmacists and technicians to help screen, identify, and link to care individuals with, or at risk of developing substance use disorders. DHHS will consult with the Community Pharmacy Enhanced Services Network (CPESN) when developing strategies that AMH care teams can implement to prevent opioid abuse. PHPs shall develop clinical programs to support pharmacy quality measures and that are consistent with the Community Pharmacy Enhanced Services Network and other DHHS and PCCM pharmacy program initiatives when developing pharmacy clinical programs.

The Evolution of CPESN from CCNC to MPSC to CPESN USA Voluntary NC CPESN Established at Request of CCNC PCPs Multi-State Pharmacy Collaborative Catalyze expansion of high-performing networks across America Provide a venue to connect pharmacists to share best practices CPESN USA Network of Networks to support local networks with expertise in network development, QA/QI/Practice transformation, and marketing

CPESN USA: 1400 Pharmacies in 38 Networks across 35 States CPESN USA is a Limited Liability Corporation with two member- owners: Community Care of North Carolina or CCNC with 50% ownership and the National Community Pharmacists Association or NCPA with 50% ownership. CPESN USA was established to develop and sustain local networks of community-based, high performing pharmacies that provide enhanced services for their patients. CPESN USA will empower its local networks, not compete with them. CPESN USA is governed by a Board of Managers from their local networks. Currently, there are 38 local networks across 35 states.

CPESN USA is a Clinically Integrated Network of Pharmacies High quality, high integrity, high performing pharmacies currently have no way of organizing to express their value and clinical contribution to the rest of the care team Concern that the providers themselves (the pharmacies) do not play an active role in engagement of payers and payer contracting Concern that clinical programs of the future will involve other care team members that are clinically integrated Simply put: no clinical integration means no exploration or negotiation of new payment models or improvements on existing payment models. Prospective and Retrospective Quality Data

Introducing Mutual CPESN Mutual CPESN (Community Pharmacy Enhanced Services Network) will function as a network of high performing community pharmacies offering enhanced services Mutual CPESN will operate as an independent subsidiary of Mutual Drug The Mutual Drug Board of Directors has approved a start-up loan for one year of operating costs for Mutual CPESN, which will be paid back in full over time

What will Mutual CPESN Do? Build on the momentum generated by the CCNC Grant Program in North Carolina Aggregate pharmacies offering enhanced services to generate opportunities for the network through two key channels: 1. Payment 2. Referrals Support pharmacies in implementation of enhanced services, maintaining quality, and developing best practices

How does Mutual CPESN Operate? Mutual Drug Board of Directors Mutual CPESN Oversight Committee Mutual CPESN Luminaries CEO Executive Director Wholesaler Operations Mutual CPESN Working Groups Network Operations QA/QI Service Sets Payer and Partner Relations

How does Mutual CPESN Operate? Mutual CPESN Oversight Committee: - Dave Marley - Mike Griffin - Whit Moose - Neal O Neal Mutual CPESN Luminaries: - Lori Altman - Tiffany Barber - Joe Moose - Rakesh Patel - Tim White (Lead) Mutual CPESN Executive Director: Patrick Brown Mutual CPESN Working Groups: - Network Operations: How does the Network Operate? - Service Sets: What do the pharmacies offer? - Quality Assurance and Quality Improvement: How do we maintain quality? - Payer and Partner Relations: Who should we be working with?

Meeting/Oversight Schedule Network Operations Every Monday, 8:00 AM Service Sets Second Friday, 9:00 AM Payer/Partner Relations Third Wednesday, 8:00 AM QA and QI Third Friday, 8:00 AM Oversight Committee Last Thursday, 8:00 AM Luminary Board Last Wednesday, 8:00 AM Mutual CPESN Newsletter Monthly (last week of the month)

Payer and Partner Channels Medicaid MCOs Accountable Care Organizations/Physician Networks Medicare Advantage Plans Commercial Insurance Self-Insured Employers Health Systems

Payer and Partner Engagements Medicaid Bridge 225 Pharmacist Signatures delivered to Secretary Cohen MCOs Engaged with three MCOs pursuing bids Signed one letter of intent (Aetna) Commercial Payers Two engagements Independent PBMs Three groups interested in pursuing self-insured business Transparent PBM model+ disease management Health Systems Two referral engagements (transitions of care) ACOs Pursuing regional referral program

The Network Adequacy Imperative Network Adequacy Metrics Population Adequacy Geographic Adequacy <30,000 Excellent >95% Excellent 30,000-40,000 Good 90-95% Good 40,000-50,000 Fair 85-80% Fair >50,000 Insufficient <85% Insufficient

The Network Adequacy Imperative 342 Pharmacies 256 Pharmacies 205 Pharmacies Network Adequacy Metrics Population Adequacy Geographic Adequacy <30,000 Excellent >95% Excellent 30,000-40,000 Good 90-95% Good 40,000-50,000 Fair 85-80% Fair >50,000 Insufficient <85% Insufficient

What do I need to do to Participate?

What do I need to do to Participate? 1. Sign the CPESN USA Pharmacy Participation Agreement CPESN USA began assessing an $85 per pharmacy per month participation fee on 4/1/18 Fees will be collected through ACH Bank Drafts this paperwork is included in the participation agreement and can be filled out separately for pharmacies who have already signed a USA agreement

What do I need to do to Participate? 1. Sign the CPESN USA Pharmacy Participation Agreement CPESN USA began assessing an $85 per pharmacy per month participation fee on 4/1/18 Fees are collected through ACH Bank Drafts this paperwork is included in the participation agreement and can be filled out separately for pharmacies who have already signed a USA agreement 2. Sign the Mutual CPESN Pharmacy Participation Agreement No fees right away Participation fees are likely to ensure financial independence of the organization, will be announced with 90 days notice

What do I need to do to Participate? 1. Sign the CPESN USA Pharmacy Participation Agreement CPESN USA began assessing an $85 per pharmacy per month participation fee on 4/1/18 Fees are collected through ACH Bank Drafts this paperwork is included in the participation agreement and can be filled out separately for pharmacies who have already signed a USA agreement 2. Sign the Mutual CPESN Pharmacy Participation Agreement No fees right away Participation fees are likely to ensure financial independence of the organization, will be announced with 90 days notice 3. Engage with a Pharmacy ecare Plan Vendor Pioneer, QS1, Creative Pharmacist, PrescribeWellness, etc

CPESN USA Fees Why are Participation Fees Necessary? Fund Operations Shared Investment in Quality Assurance and Reporting a requirement for Clinical Integration Clinical Integration allows for: Collective Marketing of all Participants Direct Negotiation with Payers Partnerships and Risk-Bearing Arrangement with Other Providers

CPESN USA Fees What are Participation Fees Used For? Facilitating Network Collaboration & Providing Support Services for Local Networks Offering Subject Matter Expertise & Network Consultation Services Driving Quality Improvement, Quality Assurance, & Practice Transformation Initiatives Providing Marketing Services & Promotional Materials for Local Networks Offering Insights & General Guidance

CPESN USA Fees Who Determines the Participation Fee Amount? CPESN USA is Governed by Board Managers from the Local CPESN Networks Budgeting process starts in March and Approved by Board in May of each year Based on: Number of Participating Pharmacies Required Operations and Capacity as Directed by Managers Can be Reset or Changed by Managers each year higher or lower Operates much like Homeowners Association Dues

CPESN USA Fees How do I Pay my Participation Fees? Fees are based on a per roof top model (again, much like an HOA) and are applied based on the number of pharmacies listed in the most current version of each executed Participation Agreement CPESN USA uses ACH drafting to collect Participation Fees

CPESN USA Fees As a participating pharmacy, what do I get? You are making an investment in your local CPESN network

What about the Local Fees? Three key revenue streams for financial sustainability of Mutual CPESN 1. Local Pharmacy Participation Fees 2. Administrative Fees on Central Reimbursements 3. CPESN USA Financial Support While the network will be open to all willing and able pharmacies, Mutual Drug members will receive discounted participation fees

The Bottom Line Mutual CPESN is committed to creativity, efficiency, and transparency, to ensure maximum value to participating pharmacies Setting up an independent business entity is necessary for a network supported by Mutual to be successful Skin in the Game through participation fees is a critical element to maintain Clinical Integration and allow contracting opportunities We need a solid network of pharmacies (200-300 across North Carolina) to generate opportunities for pharmacies AND for this organization to be sustainable

Next Steps Complete agreements via DocuSign Engage an ecare Plan Vendor Consider participating in a Mutual CPESN Working Group Let us know of pharmacies that we should be recruiting Let us know if you know of potential payers and partners

Questions? Patrick Brown pbrown@mutualdrug.com Tim White twhite@hwpharmacies.com Joe Moose joe@moosepharmacy.com Tiffany Barber info@hillsboroughpharmacync.com Rakesh Patel rrpatel89@yahoo.com Lori Altman bayboropharmacy@gmail.com